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504 The Journal of Thoracic and CardioObjectives: Surgical treatment for ischemic mitral regurgitation has become more
aggressive. However, no clinical study has demonstrated that surgical correction of
chronic ischemic mitral regurgitation improves survival. We used 4 well-developed
ovine models of postinfarction left ventricular remodeling to test the hypothesis that
ischemic mitral regurgitation does not significantly contribute to postinfarction left
ventricular remodeling.
Methods: Infarction of 21% to 24% of the left ventricular mass was induced by means
of coronary ligation in 77 sheep. Infarctions varied only by anatomic location in the left
ventricle: anteroapical, n  26; anterobasal, n  16; laterobasal, n  9; and postero-
basal, n 20. Six additional sheep had ring annuloplasty before posterobasal infarction.
End-systolic and end-diastolic left ventricular volume, end-systolic muscle-to-cavity
area ratio, left ventricular sphericity, ejection fraction, and degree of ischemic mitral
regurgitation, as determined by means of quantitative echocardiography, were assessed
before infarction and at 2, 5, and 8 weeks after infarction.
Results: All infarcts resulted in significant postinfarction remodeling and decreased
ejection fraction. Anteroapical infarcts lead to left ventricular aneurysms. Only postero-
basal infarcts caused severe and progressive ischemic mitral regurgitation. Remodeling
because of posterobasal infarcts was not more severe than that caused by infarcts at other
locations. Furthermore, prophylactic annuloplasty prevented the development of mitral
regurgitation after posterobasal infarction but had no effect on remodeling.
Conclusion: The extent of postinfarction remodeling is determined on the basis of
infarct size and location. The development of ischemic mitral regurgitation might not
contribute significantly to adverse remodeling. Ischemic mitral regurgitation is likely a
manifestation rather than an important impetus for postinfarction remodeling.
Ischemic mitral regurgitation (IMR) is mitral regurgitation (MR) that iscaused by a myocardial infarction (MI) and subsequent infarction-inducedremodeling.1 IMR likely affects 1.2 to 2.1 million patients in the UnitedStates, with more than 400,000 patients having moderate-to-severe MR.1These numbers are expected to progressively increase as the populationrapidly ages and more patients survive acute MI.
It is widely believed that the surgical correction of IMR is beneficial, and mostof the current literature has focused on whether valve repair or replacement is
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CDpreferable.2,3 However, scant data exist to support the com-
monly held assumption that elimination of IMR improves
survival or affects the remodeling process. In fact, the most
credible data would suggest that the surgical treatment of
IMR influences long-term survival very little.2-4
These clinical data, as well as experimental data from our
laboratory,5 have led us to hypothesize that IMR is a man-
ifestation of infarction-induced remodeling that does not
significantly contribute to the process that leads to progres-
sive ventricular dilatation and associated congestive heart
failure.
Four ovine models of MI were used to test this hypoth-
esis. Infarcts in all 4 models are similarly sized6-10 but
involve different regions of the left ventricle (LV): an-
teroapical, anterobasal, laterobasal, and posterobasal. Only
the posterobasal infarct model reliably results in significant
IMR.7,9 The outcome of remodeling in a group of animals
having an untreated posterobasal infarct was compared with
remodeling induced by anteroapical, anterobasal, and lat-
erobasal infarcts. The untreated posterobasal infarct group
was also compared with a group of animals that had a ring
annuloplasty device placed before posterobasal infarction
with the intent of preventing the development of IMR (the
posterobasal with annuloplasty [PBA] group). If IMR influ-
ences the remodeling process, the untreated posterobasal
infarct group is expected to have more severe changes in LV
size and shape than the other 4 groups of animals.
Methods
Infarction Models and Experimental Groups
Infarction of 21% to 24% of the LV mass was induced by means
of coronary ligation in 77 sheep. Infarctions varied only by ana-
tomic location in the LV. An anteroapical infarction involving
22%  3% of the LV mass was created in 26 animals by ligating
the left anterior descending artery and its second diagonal branch
40% of the distance from the apex to the base of the heart.6 This
infarction reproducibly results in large LV aneurysms after 8
weeks of remodeling. Sixteen sheep had an anterobasal infarction
involving 24%  2% of the LV that was produced by ligating the
first and second diagonal branches of the left anterior descending
artery.7,8 Nine animals had a laterobasal infarction produced by
ligating the first and second marginal branches of the circumflex
artery. This infarct involves 23%  3% of the LV mass.9,10
Twenty animals had a posterobasal infarction produced by ligating
the second and third obtuse marginal branches of the circumflex
coronary artery, which involves 21%  4% of the LV mass and
routinely results in IMR.9,11 Finally, 6 additional sheep had a ring
annuloplasty before posterobasal infarction.5
Surgical Protocol
Dorset male hybrid sheep (Animal Biotech Industries, Doyles-
town, Pa) weighing 35 to 40 kg were used for this study. Animals
were treated under an experimental protocol approved by the
University of Pennsylvania’s Institutional Animal Care and Use
Committee and in compliance with the “Guide for Care and Use of
The Journal of ThoraciLaboratory Animals.” Anesthesia was induced with thiopental
sodium (10-15 mg/kg intravenously) and the animals were intu-
bated. Anesthesia was maintained with isoflurane (1.5%-2%) and
oxygen. Under aseptic conditions, all animals underwent left tho-
racotomy. Polypropylene snares were loosely placed around the
appropriate coronary arteries. Seventy-one animals underwent clo-
sure of the thoracotomy and recovery. Six animals underwent
placement of a 24-mm mitral annuloplasty ring (Carpentier-Ed-
wards Physio, Edwards Lifesciences, Irvine, Calif) with standard
cardiac surgical techniques after snares were placed to produce a
posterobasal infarct. After termination of cardiopulmonary bypass,
these animals underwent closure of the thoracotomy and recov-
ered.5
Baseline Data and Infarction
Ten to 14 days after initial instrumentation, the sheep were again
anesthetized. The surface electrocardiogram and arterial blood
pressure were continuously monitored (Sonometrics Inc, London,
Ontario, Canada) and recorded during all data collection proce-
dures. A high-fidelity pressure transducer (SPC-350; Millar Instru-
ments Inc, Houston, Tex) was inserted through a femoral artery
into the LV for continuous LV pressure monitoring (78534c mon-
itor; Hewlett-Packard, Palo Alto, Calif). A pulmonary artery cath-
eter (131-h, 7F; Baxter Healthcare Corp, Deerfield, Ill) was placed;
thermodilution cardiac output was measured in triplicate at each
time point for each animal. Animals were disconnected from the
ventilator and atrially paced at 120 beats/min during data collec-
tion. After baseline hemodynamic and echocardiographic data
were recorded, the subcutaneous snares were exposed, tightened,
and tied to produce infarction. Each animal received magnesium
sulfate, bretylium tosylate (INN: bretylium tosilate), and lidocaine
before infarction. Hemodynamic and echocardiographic data were
again collected 30 minutes after infarction.
Echocardiography
Quantitative, 2-dimensional, subdiaphragmatic echocardiograms
were obtained before infarction and at 30 minutes and 2, 5, and 8
weeks after infarction. A sterile midline laparotomy (or a right or
left subcostal incision) was made, and subdiaphragmatic, quanti-
tative, 2-dimensional echocardiographic images were obtained
with a 5-MHz probe (77020A, Hewlett-Packard). Images were
recorded on VHS videotape at 30 Hz (Panasonic AG-6300 VHS
Recorder). LV short-axis images at 3 levels (the tips of the pap-
illary muscles, the bases of the papillary muscles, and the apex)
and 2 orthogonal long-axis views were recorded. Previous reports
have validated the reproducibility and effectiveness of this tech-
nique for evaluating LV remodeling in sheep.5,12,13 LV end-
systolic volume (LVESV) and LV end-diastolic volume (LVEDV)
were calculated by using Simpson’s rule.14 Ejection fraction was
calculated from LVESV and LVEDV. End-systolic muscle-to-
cavity area ratio (ESMCAR) was also determined at each time
point. Ventricular sphericity at end systole was assessed as the
ratio of LVESV to the volume of a sphere with a diameter equal to
the LV long-axis dimension. This ratio approaches unity as the
ventricle becomes more spherical. All measured echocardio-
graphic indexes of remodeling were normalized to their baseline
values. The degree of MR was determined quantitatively by as-
sessing the area of the regurgitant jet as a percentage of left atrial
c and Cardiovascular Surgery ● Volume 129, Number 3 505
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used: grade 1, less than 20%; grade 2, 20% to 40%; grade 3, 40%
to 60%; and grade 4, greater than 60%.15
Follow-up Studies
Hemodynamic and echocardiographic data were collected at 30
minutes and 2, 5, and 8 weeks after infarction. After the 9-week
study, the animals were put to death. The heart was excised and
photographed to confirm infarction size and location.
Statistics
Measurements are reported as means  SEM. Between-group
differences in all continuous dependent variables (ie, all but MR
grade) were compared by analysis of variance for repeated mea-
sures. If analysis of variance revealed significant differences, the
Student t test with the Bonferroni correction was used to assess
differences between groups at specific time points after infarction
(SPSS, Chicago, Ill). Differences in the degree of MR between
groups were assessed by the nonparametric Kruskal-Wallis test.
TABLE 1. Hemodynamic data for 5 ovine myocardial infarc
Group MAP
Anteroapical
Preinfarct 75 7
Postinfarct 63 6
Week 2 69 6
Week 5 69 4
Week 8 71 5
Anterobasal
Preinfarct 65 5.6
Postinfarct 59 4.0
Week 2 69 2.1
Week 5 71 6.5
Week 8 66 2.3
Laterobasal
Preinfarct 69 6
Postinfarct 59 5
Week 2 72 4
Week 5 74 3
Week 8 70 5
Posterobasal
Preinfarct 72 7
Postinfarct 63 4
Week 2 69 4
Week 5 71 5
Week 8 73 4
Posterobasal with annuloplasty
Preinfarct 74 8
Postinfarct 62 3
Week 2 70 5
Week 5 75 4
Week 8 73 4
MAP, Mean arterial pressure; LVEDP, left ventricular end-diastolic pressu
*Significant difference from before infarction (P  .05).The Mann-Whitney test with the Bonferroni correction was used to
506 The Journal of Thoracic and Cardiovascular Surgery ● Marevaluate the differences in MR between any 2 groups at specific
time points.
Results
Hemodynamic Data
Hemodynamic data are presented in Table 1. No significant
differences in LV end-diastolic pressure, central venous
pressure, pulmonary artery diastolic pressure, mean arterial
pressure, or cardiac output were observed between groups.
Echocardiographic Data
Echocardiographic data are summarized in Table 2. As
expected, the posterobasal group had progressive and mod-
erate-to-severe MR (2.8  0.2) after 8 weeks. IMR was
effectively prevented by the ring annuloplasty in the PBA
group. None of the remaining 3 groups (anteroapical, an-
terobasal, and laterobasal) had significant IMR as a result of
remodeling (Figure 1). All the groups, irrespective of infarct
models
LVEDP CVP CO
1.7 1.0 9.6 2.6 2.4  0.7
8.2 3.5* 11.9 3.2 2.3  0.9
6.4 5.7* 8.2 2.5 2.0  0.8
6.0 1.9* 7.6 2.1 1.9  0.4
5.7 2.8* 8.3 3.0 1.6  0.7
1.7 1.0 4.4 0.9 2.9  0.8
5.7 2.8* 5.2 2.1 2.3  0.8
6.0 1.9* 5.0 2.3 2.8  0.9
6.6 2.3* 6.1 1.9 2.7  0.7
8.2 3.5* 5.9 2.7 2.4  0.9
1.8 1.1 10.2  3.1 2.5  0.5
6.9 3.0* 13.3 2.2 2.4  0.7
6.5 5.8 11.4  3.0 2.2  0.9
6.4 1.8* 12.1 2.4 2.0  0.9
6.0 2.9* 11.6 3.2 1.8  0.8
5.0 4.0 12.1  4.7 3.5  1.1
7.5 5.7 12.7  9.5 3.9  1.2
5.6 2.1 12.6  5.0 3.7  0.7
6.6 1.4 10.8  4.4 3.7  1.0
5.0 1.3 11.0  4.3 3.7  0.9
6.0 6.3 13.6  6.8 3.7  1.3
6.0 4.6 11.0  5.1 3.3  1.0
6.2 9.0 12.0  8.6 2.8  1.4
7.0 1.9 10.0  1.4 3.4  1.0
6.2 2.3 14.6  5.0 3.2  1.3
VP, central venous pressure; CO, cardiac output.tion
re; Clocation or annuloplasty placement, had adverse infarction-
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enlargement and shape changes.
In all 5 groups, LVESV and LVEDV increased signifi-
cantly, reflecting postinfarction remodeling over the 8-week
period (Figure 2); ejection fraction also decreased in all
groups (Table 2). The only significant differences in
LVESV and LVEDV between groups at 8 weeks occurred
between the laterobasal infarct group (LVESV, 1.91 0.13;
LVEDV, 1.59  0.08) and the anteroapical infarct group
(LVESV, 2.38  0.12; LVEDV, 1.78  0.07; P  .05). No
differences in these parameters were observed between the
other groups at 8 weeks (Table 2).
With regard to ventricular shape, all groups had signifi-
cant increases in ventricular sphericity (Figure 3) and de-
TABLE 2. Echocardiographically determined indexes of in
Group MR LVESV
Anteroapical
Preinfarct 0.34 0.12 1.00 0.00
Postinfarct 0.96 0.25 1.30 0.07*
Week 2 0.46 0.20 1.87 0.18*
Week 5 0.36 0.24 2.06 0.16*
Week 8 0.60 0.20 2.38 0.12*
Anterobasal
Preinfarct 0.47 0.12 1.00 0.00
Postinfarct 1.06 0.25 1.14 0.10
Week 2 0.77 0.20 1.63 0.14*
Week 5 0.67 0.24 1.88 0.19*
Week 8 0.70 0.20 2.04 0.24*
Laterobasal
Preinfarct 0.17 0.08 1.00 0.00
Postinfarct 0.28 0.22 0.97 0.04†
Week 2 0.50 0.25 1.45 0.20*
Week 5 0.22 0.12 1.72 0.11*
Week 8 0.32 0.23 1.91 0.13*
Posterobasal
Preinfarct 0.40 0.12 1.00 0.00
Postinfarct 1.98 0.20*†‡§ 1.05 0.09
Week 2 2.41 0.17*†‡§ 1.51 0.13*
Week 5 2.35 0.27*†‡§ 1.57 0.20*
Week 8 2.83 0.21*†‡§ 2.18 0.18*
Posterobasal with annuloplasty
Preinfarct 0.60 0.24 1.00 0.00
Postinfarct 0.80 0.20 1.17 0.07*
Week 2 0.40 0.24 1.58 0.12*
Week 5 0.40 0.24 1.85 0.18*
Week 8 0.60 0.24 2.05 0.28*
MR, Mitral regurgitation; LVESV, left ventricular end-systolic volume; LVED
area ratio; EF, ejection fraction. LVESV, LVEDV, ESMCAR, sphericity, and
*P  .05 within groups when compared with the preinfarct subset.
†P  .05 between groups when compared with the anterobasal group.
‡P  .05 between groups when compared with the anteroapical group.
§P  .05 between groups when compared with the laterobasal group.
P  .05 between groups when compared with the posterobasal group.creases in ESMCAR (Figure 4) as a result of remodeling.
The Journal of ThoraciThe anteroapical group was significantly less spherical than
the basilar infarct groups (anterobasal, laterobasal, postero-
basal, and PBA) at 8 weeks. No difference in sphericity
could be established between any of the 4 groups having a
basilar infarct. ESMCAR was significantly less at 8 weeks
in the posterobasal and PBA groups than in the anteroapical,
anterobasal, and laterobasal groups. However, there was no
difference in ESMCAR between the posterobasal and PBA
groups.
Discussion
The extent of ventricular remodeling is a powerful prognos-
ticator for longevity in patients who survive an acute MI.16
The data from this study strongly suggest that infarct size
ion induced remodeling in 5 ovine infarction models
LVEDV ESMCAR Sphericity EF
1.00 0.00 1.00 0.00 1.00  0.00 1.00 0.00
1.16 0.05* 1.17 0.05* 0.89 0.05* 1.29 0.41
1.42 0.11* 0.90 0.05 1.03  0.07 0.98 0.33
1.56 0.11* 0.88 0.07* 1.17 0.08* 0.87 0.36
1.78 0.07* 0.86 0.06* 1.20 0.06* 0.83 0.32*
1.00 0.00 1.00 0.00 1.00  0.00 1.00 0.00
1.14 0.07* 0.83 0.09*‡ 0.92 0.08 1.20 0.15
1.43 0.11* 0.85 0.05* 1.21 0.07* 0.92 0.13
1.63 0.16* 0.74 0.07* 1.35 0.10* 0.86 0.12
1.64 0.11* 0.75 0.06* 1.35 0.13*‡ 0.76 0.09*
1.00 0.00 1.00 0.00 1.00  0.00 1.00 0.00
1.04 0.07 0.92 0.03*‡ 0.91 0.04* 1.10 0.07
1.30 0.07* 0.85 0.07* 0.89 0.15 0.69 0.11*
1.48 0.11* 0.90 0.10* 1.07 0.09 0.78 0.07*
1.59 0.08*‡ 0.83 0.05* 1.37 0.08*‡ 0.75 0.06*
1.00 0.00 1.00 0.00 1.00  0.00 1.00 0.00
1.18 0.04* 0.87 0.06*‡ 0.90 0.09 1.06 0.08
1.36 0.07* 0.78 0.05* 1.19 0.11* 0.92 0.06
1.45 0.10* 0.72 0.07* 1.17 0.14 0.64 0.08*
1.76 0.10* 0.67 0.04*†‡§ 1.43 0.10*‡ 0.74 0.07*
1.00 0.00 1.00 0.00 1.00  0.00 1.00 0.00
1.08 0.03* 0.74 0.04*‡ 1.03 0.09 0.86 0.11
1.33 0.08* 0.76 0.12* 1.37 0.07* 0.71 0.05*
1.53 0.09* 0.72 0.12* 1.43 0.11* 0.72 0.09*
1.68 0.14* 0.65 0.10*†‡§ 1.43 0.06*‡ 0.75 0.14*
ventricular end-diastolic volume; ESMCAR, end-systolic muscle-to-cavity
e normalized to baseline.farct
‡
‡
V, left
EF arand, to a lesser degree, infarct location determine the out-
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anatomic manifestation of remodeling, with anteroapical
infarcts leading to LV aneurysm and posterobasal infarcts
causing progressive MR; the other basal infarcts result in a
dilated cardiomyopathy without MR or LV aneurysm. The
progressive and significant IMR that develops after the
posterobasal infarct did not exacerbate any of the measured
parameters of remodeling when compared with similarly
sized infarcts in other locations within the 8-week study
period. Ring annuloplasty was highly effective in prevent-
ing the development of IMR after the posterobasal infarct;
however, it had no demonstrable effect on postinfarction
ventricular remodeling during the 8 week study period.
These data support the conclusion that IMR should be
considered a manifestation of the remodeling process,
which is dependent on infarct location but does not drive
changes in ventricular size and shape. The data further
suggest that the surgical correction of fully developed IMR
might not affect ventricular remodeling and survival.
These findings, although seemingly counterintuitive, are
consistent with clinical experience. The increasing inci-
dence of IMR, combined with improved mitral valve repair
techniques and a long history of surgical success in treating
Figure 1. Degree of MR graded on a scale of 0 to 4 (0, no MR; 4,
severe MR; see text) as determined by means of serial, transdia-
phragmatic, quantitative, 2-dimensional echocardiography during
infarction-induced remodeling in 5 ovine infarct models. The
anteroapical (dashed line, filled squares), anterobasal (dashed
line, filled triangles), laterobasal (dashed-dotted line, open trian-
gles), posterobasal (solid line, filled circles), and posterobasal
with annuloplasty (dotted line, open circles) groups are shown.other valve diseases, has lead to heightened interest in and
508 The Journal of Thoracic and Cardiovascular Surgery ● Mara very aggressive approach to IMR among surgeons and
cardiologists. Most research has been focused on determin-
ing whether valve repair is preferable replacement or
whether mild grades of IMR should be addressed surgically;
however, the best and most recent clinical studies have
failed to provide convincing evidence that the surgical treat-
ment of IMR improves survival over medical manage-
ment.2-4
The failure of IMR to measurably contribute to adverse
remodeling in these relatively short-term ovine models is
indicative of the extreme impetus for remodeling that a
moderately sized transmural MI imposes on the LV. It
appears that the lessons learned regarding the indications for
intervention in isolated mitral valve disease might not be
directly applicable to patients with IMR.
This report builds on and adds to earlier work from our
laboratory comparing untreated remodeling after postero-
basal infarction with prophylactic ring annuloplasty or pro-
phylactic ventricular restraint. In the posterobasal infarct
model, ring annuloplasty is highly effective in preventing
the development of IMR but has no demonstrable effect on
remodeling. In contrast, ventricular wrapping reduced acute
infarct expansion, preserved ejection fraction, and signifi-
cantly improved measured parameters of postinfarction re-
modeling. Additionally, ventricular wrapping was almost as
Figure 2. LVESV as determined by means of serial, transdiaphrag-
matic, quantitative, 2-dimensional echocardiography during in-
farction-induced remodeling in 5 ovine infarct models. The an-
teroapical (dashed line, filled squares), anterobasal (dashed line,
filled triangles), laterobasal (dashed-dotted line, open triangles),
posterobasal (solid line, filled circles), and posterobasal with
annuloplasty (dotted line, open circles) groups are shown.effective as ring annuloplasty in preventing the develop-
ch 2005
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expansion (stretching) is the critical inciting phenomenon
that drives postinfarction remodeling. We further posited
that well-recognized clinical phenomena, such as LV aneu-
rysm and IMR, were likely just manifestations of remodel-
ing that are dependent on infarct location but contribute
little to perpetuating the remodeling process. By including
the other infarct locations in this analysis, we were able to
test these hypotheses and conclude that postinfarct remod-
eling is dependent on infarct size and occurs regardless of
the infarct location, whether complicated by IMR or LV
aneurysm. Therefore this study, in conjunction with our
previous work,5,13,14,17,18 emphasizes infarct expansion as
an important instigating mechanical phenomenon that
drives remodeling and identifies it as a legitimate surgical
target that might be exploited to prevent (rather than re-
verse) remodeling.
Recent laboratory19,20 and clinical21 studies have shown
that expansion (stretching) of a transmural MI initiates a
progressive myopathic process in normally perfused myo-
cardium. This phenomenon is initially localized to myocar-
dium immediately adjacent to the infarct but extends during
the remodeling process to convert contiguous and normally
perfused myocardium into hypocontractile remodeled myo-
Figure 3. LV sphericity as determined by means of serial, trans-
diaphragmatic, quantitative, 2-dimensional echocardiography
during infarction-induced remodeling in 5 ovine infarct models.
The anteroapical (dashed line, filled squares), anterobasal
(dashed line, filled triangles), laterobasal (dashed-dotted line,
open triangles), posterobasal (solid line, filled circles), and pos-
terobasal with annuloplasty (dotted line, open circles) groups are
shown.cardium. The stretch-induced myopathic process has been
The Journal of Thoraciassociated with myocyte apoptosis9 and disruption of the
extracellular matrix caused by activation of matrix metal-
loproteinases.22 The failure of surgical reshaping operations
to improve survival in patients with ischemic cardiomyop-
athy strongly suggests that infarct-induced myopathy is very
difficult to reverse once established.23-25 Using contrast
echocardiography, Jackson and colleagues26 have demon-
strated that early postinfarction geometric changes consis-
tent with increased regional wall stress occur in the border
region adjacent to infarcts undergoing early expansion and
subsequent remodeling. A finite-element analysis by Guc-
cione and coworkers19 confirms these findings and also
demonstrates that once the myopathic process is fully de-
veloped, contractile function in nonischemic myocardium is
impaired beyond what would be expected from changes in
LV geometry and stress distribution. Therefore, early after
infarction, loss of contractility is due to mechanical factors;
as remodeling progresses, the geometric contribution
(stress) to myocardial dysfunction is likely outstripped by
the myopathic phenomenon that it initiates in normally
perfused myocardium.
Although the results of this study are intriguing and
provocative, there are limitations that warrant caution when
generalizing the conclusions presented here to patients. It is
not known whether the contribution of IMR to remodeling
Figure 4. ESMCAR as determined by means of serial, transdia-
phragmatic, quantitative, 2-dimensional echocardiography during
infarction-induced remodeling in 5 ovine infarct models. The
anteroapical (dashed line, filled squares), anterobasal (dashed
line, filled triangles), laterobasal (dashed-dotted line, open trian-
gles), posterobasal (solid line, filled circles), and posterobasal
with annuloplasty (dotted line, open circles) groups are shown.becomes progressively more important as infarct material
c and Cardiovascular Surgery ● Volume 129, Number 3 509
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less of an impetus for remodeling. This question will be
addressed by a longer and more clinically relevant fol-
low-up period (ie, 6-12 months) of these ovine infarct
models. Such experiments are ongoing in our laboratory.
The current study did not address the affect of IMR on
symptoms. It is widely believed that the surgical treatment
of IMR improves heart failure symptoms and reduces sub-
sequent hospitalization. Confirmation of this clinical im-
pression would require a randomized clinical trial.
The data presented here contribute to a growing body
of work that casts doubt on the ability of surgical proce-
dures to affect longevity in patients with end-stage heart
failure.2-4,22-24,27 All currently available operations are de-
signed to address the structural manifestations of fully de-
veloped remodeling and are dependent on the assumption
that the remaining uninfarcted myocardium is capable of
better contractile function once a more normal geometry is
established. The veracity of this assumption is becoming
more dubious.
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Discussion
Dr Frank W. Sellke (Boston, Mass). Doesn’t this go against
conventional wisdom and common sense. That is, if you have MR,
you are going to have volume overload, and that has to contribute,
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CDat least in some way, to the geometry of the ventricle over time.
Am I missing the point?
If you have a leaky valve, you are going to have different
pressures within the heart, and you tend to have volume overload.
How can that not contribute to the remodeling of the heart?
Dr Moainie. I think the pathology is located in the myocar-
dium. Although there has to be some effect of the regurgitation in
terms of volumes, it is so minuscule in terms of its effect that the
true pathology lies in the myocardium and in the infarct-induced
remodeling, and the variable is so minor that it really does not
affect the results of the remodeling.
Dr Frank A. Pigula (Boston, Mass). Did you look at the left
atrial dimensions at all, or did you assess left atrial function?
Dr Moainie. We did not focus on left atrial function. We
looked at ventricular function and overall LV function.
Dr Bradley S. Allen (Houston, Tex). One question about your
controls. Like Dr Sellke, I would have imagined that if you had
mitral valve regurgitation, you would get some sort of volume
overload and ventricular remodeling.
The question, therefore, is what happens if you just cause mitral
valve regurgitation in hearts for 8 weeks without an infarction.
Does the ventricle get bigger? If indeed there is ventricular en-
largement (remodeling) in 8 weeks with just MR (no infarction),
then it would follow that you are correct and the pathology is all
in the ventricle. However, if the ventricular enlargement is mini-
mal after 8 weeks of MR alone, then it might be that your time
frame is too short to allow these conclusions because the MR has
not had sufficient time to dilate the heart.
I would also echo what Dr Pigula was saying about left atrial
size. If the MR increases left atrial size, this might lead to arrhyth-
mias, and therefore it might still be important to correct the MR.
Dr Moainie. In response to your first question, the second set
of experiments is more focused at addressing that issue. Because
the only difference between those 2 groups of animals is the
presence of MR, that is the only variable that is different. They
have the identical infarct. Therefore, you would think that if the
MR was the variable that was contributing—if it had any effect on
the changes in volumes—that the group that had a prophylactic
annuloplasty ring and therefore had no MR during the entire
course of the study should, by virtue of that, have a decreased
amount of dilatation. There should be some difference that is
demonstrable at 8 weeks. Even though it is only 8 weeks, there
should be a demonstrable change.
In terms of the time course, you can see that the control group
does double at 8 weeks. Therefore, clearly the 8 weeks is long
enough to demonstrate the pathology that occurs with ischemic
disease. However, eliminating the MR made no difference. There-
fore, it is hard to imagine that even if you followed those animals
out for 16 weeks that anything would change in that course.
In terms of the arrhythmia issue, that is something that obvi-
ously should be addressed separately, but that was not the focus of
this study.
The Journal of ThoraciDr W. Randolph Chitwood, Jr (Greenville, NC). Have you
done a similar type of study in which you induced ischemia alone
and did not allow a true infarction to develop?
Dr Moainie. We have not. One of the advantages of sheep is
that they have no collateral circulation, and therefore they are very
pure models of infarction. But because they have no collaterals, for
creating ischemia, you have to do this with amyloid constrictors or
something other than localized infarcts, and we have not really
delved into that area.
Dr Chitwood. So the clinical call here is that we are treating
the symptoms of MR and not anything else. Is that the call?
Dr Moainie. I think the results of this study really beg for a
clinical study that would look at just the question that you have
posed, a study that would look at a randomized clinical study of
treatment of IMR and not treatment of IMR in a group of patients
to see whether, in fact, we are affecting survival at all or if we are
purely operating on symptoms.
Dr Paul Kurlansky (Miami Beach, Fla). It is a very interesting
study and a very provocative one. But I am a little concerned about
too readily drawing the wrong clinical implications from it.
I think one thing that you are clearly dealing with here is the
evolution of a cardiomyopathy and what the factors that cause
remodeling might be, as it were. What is the remodeling process,
and what are the key factors in the evolution of the remodeling
process?
What it seems that you have shown fairly convincingly is that
MR is not a key factor in the initial ischemic remodeling process.
Whether or not MR has an aggravating or accelerating effect in the
long term, once somebody has a cardiomyopathic process, it is a
totally different issue.
These animals were followed up for 8 weeks. There are sig-
nificant clinical data that seem to indicate that patients who already
have established cardiomyopathy and have MR have a severely
worse prognosis than those with cardiomyopathy who do not have
MR. Therefore, it might be that although the MR is not key in the
evolution of the cardiomyopathy, in the maintenance and long term
and evolution and prognosis and ability to treat it, it might be a key
factor. I also think that is something that is important to try to
distinguish in the long-term evaluation of your results.
Dr Moainie. There are a number of ways one can look at the
issue that you bring out. One of the ways that I look at it is that the
presence of IMR in a group of patients with heart failure is simply
a manifestation of the severity of their disease. That it, in fact, is
kind of a chicken-or-egg phenomena. That it is not so much the
cause of their failure, but it is just a manifestation of how severe
their disease, in fact, is.
And something that would suggest that this is, in fact, the case,
is that when you look at the survival data for surgery for IMR in
the presence of failure, the survival data are not significantly
different than those of heart failure in general. Therefore I think
that, combined with the results of this study, this would suggest an
indication to perform more intensive clinical investigation of this
topic.
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